Recommended as a second-line test based on ANA results or when ANA IFA is negative but there is strong clinical suspicion of Sjögren syndrome, systemic lupus erythematosus (SLE), systemic sclerosis, or myositis
Specimen Type: Serum
Collection Tube: Serum separator tube (SST) or red top
Collection Instructions: Separate serum from cells ASAP or within 2 hours of collection. Then transfer available serum to a standard transport tube.
Volume Required: 1 mL with a minimum of 500 mcL
Storage/Transport Temperature: Refrigerated/Frozen
Stability: Ambient (up to 8 Hours), refrigerated (up to 2 weeks/14days), frozen (up to 30 days) and avoid freeze/thaw cycles with no more than 3 in total
Unacceptable Conditions: Contaminated, heat-inactivated, containing clots fibrin or gross red blood cells, or severely lipemic hemolyzed or icteric samples
Normal Human: <20
This test has been cleared by the US Food and Drug Administration and is used per manufacturer's instructions and per Exsera's SOPs. Performance characteristics were verified by Exsera in a manner consistent with CAP/CLIA requirements.
ELISA or EIA
5 Business Days
Days Performed: M-F
SSA, Anti-Sjögren's Syndrome Type A Antibodies or Anti-RO IgG Antibodies
This test detects autoantibodies to both parts of the SSA antigen, SSA 60 and SSA 52.